The ASX200 pared early gains and closed up 0.48% at 8,231 points.
A lift in the iron ore price has driven big miners higher; Fortescue was the biggest winner, up 2.7%, followed by BHP, up 1.4% and Rio Tinto, up 0.8%.
The Materials sector was the biggest gainer, up 1.5%, followed by Real Estate and Energy, both up around 1.2%.
Information Technology was the worst performing, down 0.5%.
In the Green
Telix Pharmaceuticals (ASX:TLX) closed up 4% after delivering Q4 revenue of $230M.
This marks a 46% increase over the prior-year period and a commendable 5% rise compared to Q3 2024.
Telix Pharmaceuticals has been $24.98.
Opthea (ASX:OPT) closed up 6.7% on reported new advancements in the development of its new product aimed at enhancing patient outcomes for those with wet age-related macular degeneration. According to the company, the new product has the potential to improve visual outcomes.
Opthea closed at 80 cents.
Arrow Minerals (ASX:AMD) closed up 9.1% after announcing the rapid advancement of a scoping study at its Niagara Bauxite Project in Guinea. Recent drilling has confirmed high-grade mineralisation over a substantial 14km2 area, suggesting the potential for a direct shipping ore operation.
Arrow Minerals closed at 3.6 cents.
In the Red
Mesoblast (ASX:MSB) closed down 9.25% on the completion of a capital r9.25%aise. The company has completed a global private placement primarily to its existing major U.S., U.K., and Australian shareholders.
Mesoblast finished the day at $2.55.
Vulcan Energy Resources (ASX:VUL) was down 2.4% after unveiling the production of battery-quality lithium hydroxide monohydrate at its Central Lithium Electrolysis Optimisation Plant in Frankfurt, Germany.
Vulcan Energy wrapped up at $6.00.
Ordell Minerals (ASX:ORD) closed down 12.2% after highlighting the McNabs East target in the Barimaia Gold Project in WA to be a high-priority target, finding extensive gold mineralisation through a limited diamond drilling program.
Ordell Minerals closed at 32.5 cents.